Animal models of obesity-associated chronic kidney disease

Adv Chronic Kidney Dis. 2006 Oct;13(4):374-85. doi: 10.1053/j.ackd.2006.07.003.

Abstract

Dramatic advances in basic science have been made in the past 50 years on the basis of animal models of obesity and type II diabetes. Positional-cloning strategies in rodents with spontaneous obesity have enabled landmark scientific breakthroughs and defined the molecular scaffolding for the regulation of energy homeostasis. Recently, studies in the general population suggest that obesity is an independent risk factor for chronic kidney disease. To date, most of the animal studies that investigated chronic kidney disease associated with obesity and type II diabetes have largely been descriptive. We aim to provide an overview of animal models used to investigate the mechanisms of obesity-associated chronic kidney disease. Our overview is not meant to be an exhaustive list of all animal models in the literature on this subject, but rather to illustrate the experimental approaches. Because of space limitations, we have chosen to concentrate on rodent models. These animal models will provide excellent tools for in vivo testing of molecular mechanisms. Further hypothesis-driven research into the mechanism of chronic kidney disease and their progression by use of these models will provide important insights necessary to develop therapeutic strategies for this significant complication of the worldwide epidemic of obesity and type II diabetes.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Animals, Genetically Modified
  • Diabetes Mellitus, Type 2
  • Diabetic Nephropathies
  • Dietary Fats / metabolism
  • Glycation End Products, Advanced
  • Humans
  • Hypertension / physiopathology
  • Kidney Diseases
  • Mice
  • Mice, Inbred Strains
  • Mice, Obese
  • Models, Animal*
  • Obesity / physiopathology*
  • Rats
  • Renal Insufficiency, Chronic / physiopathology*
  • Risk Factors

Substances

  • Dietary Fats
  • Glycation End Products, Advanced